Related Experiment Video
Updated: Jul 29, 2026
10:59
Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
Published on: November 18, 2013
Structure of the human apolipoprotein B gene
The Journal of Biological Chemistry
|November 25, 1986
Summary
Researchers isolated the human apolipoprotein B100 gene, finding it spans 43 kilobases with 29 exons and 28 introns. Notably, one exon is the longest ever reported for a vertebrate gene.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Human apolipoprotein B100 (apoB100) is a crucial protein involved in lipid transport.
- Understanding the genetic structure of apoB100 is vital for studying related metabolic disorders.
Purpose of the Study:
- To isolate and characterize the full human apolipoprotein B100 gene.
- To analyze the exon-intron structure and identify unusual features of the gene.
Main Methods:
- Isolation of the human apolipoprotein B100 gene using overlapping lambda clones.
- Analysis of the gene's physical extent, exon count, and intron distribution.
Main Results:
- The human apolipoprotein B100 gene was isolated and found to span over 43 kilobases.
- The gene comprises 29 exons and 28 introns, with an asymmetrical intron distribution.
- Two unusually long exons were identified, including the longest vertebrate exon reported to date (7572 base pairs).
Conclusions:
- The characterization of the human apolipoprotein B100 gene provides a foundation for further genetic and functional studies.
- The discovery of exceptionally long exons may have implications for gene regulation and protein evolution.
Related Concept Videos
02:07Organization of Genes
Overview
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
02:23RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:30Structure of a Gene
A gene is the fundamental unit of heredity. Every individual has two copies of each gene, one inherited from each parent. Although most people contain the same genes, there is a small fraction that is slightly different amongst people. A gene with a small difference in its sequence of DNA bases forms different alleles, contributing to different phenotypes.
However, only 1% of the DNA is composed of genes that encode proteins; the rest, 99% is non-coding DNA. This non-coding DNA performs...
However, only 1% of the DNA is composed of genes that encode proteins; the rest, 99% is non-coding DNA. This non-coding DNA performs...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...